AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)
NCT ID: NCT03893331
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
479 participants
OBSERVATIONAL
2019-06-13
2023-11-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AcQMap Objectively Visualize the Etiology of Recurrent AF Following a Failed AF Ablation
NCT03368781
Biatrial Global High-density Electroanatomical Mapping of Atrial Fibrillation
NCT03812601
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation
NCT02825992
Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)
NCT03613831
Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping
NCT04900831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AcQMap System
To evaluate procedural and long-term outcomes when using the diagnostic AcQMap System as an imaging and mapping system for ablation of arrhythmias in accordance with the Instructions for Use (IFU).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently scheduled for an ablation of an arrhythmia utilizing the diagnostic AcQMap System.
* Willingness, ability and commitment to participate in baseline and follow-up evaluations for the full length of the study.
* Willing and able to give written informed consent.
Exclusion Criteria
* Current enrollment in any study protocol sponsored by Acutus Medical.
* Any other condition that, in the judgment of the investigator, makes the participant a poor candidate for this procedure, the study, or compliance with the protocol (includes vulnerable patient population, mental illness, addictive disease, extensive travel away from the research center, etc.).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acutus Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon James, MD
Role: PRINCIPAL_INVESTIGATOR
James Cook University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
I.C.P.S. Hôspital Privé Jacques Cartier
Paris, , France
Klinikum Coburg
Coburg, , Germany
St. Antonius Ziekenhuis
Nieuwegein, , Netherlands
Erasmus MC Cardiologie Elektrofysiologie
Rotterdam, , Netherlands
Papworth Hospital NHS Foundation Trust
Cambridge, , United Kingdom
Royal Brompton Hospital
London, , United Kingdom
St. George's Hospital
London, , United Kingdom
James Cook University Hospital
Middlesbrough, , United Kingdom
Freeman Hospital
Newcastle upon Tyne, , United Kingdom
Norfolk and Norwich University Hospital
Norwich, , United Kingdom
John Radcliffe Hospital
Oxford, , United Kingdom
Sheffield Teaching Hospital Northern General Hospital
Sheffield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLP-AF-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.